AstraZeneca unveils $50 billion US investment as pharma tariff threat looms – Reuters

  1. AstraZeneca unveils $50 billion US investment as pharma tariff threat looms  Reuters
  2. AstraZeneca to Invest $50 Billion in U.S. by 2030 with Manufacturing Projects in Virginia  geneonline.com
  3. AstraZeneca’s $50 Billion U.S. Bet: A Strategic Play in a Tariff-Driven Pharma Landscape  AInvest
  4. Biopharmaceutical company announces multi-billion dollar plant in Virginia  WWBT
  5. Pharmaceutical company selects Virginia for multi-billion-dollar manufacturing center  WSLS

Continue Reading